HLB Therapeutics Co (XKRX:115450) Total Liabilities : ₩33,230 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Total Liabilities?

HLB Therapeutics Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩33,230 Mil.

HLB Therapeutics Co's quarterly Total Liabilities declined from Sep. 2023 (₩34,539.25 Mil) to Dec. 2023 (₩29,275.99 Mil) but then increased from Dec. 2023 (₩29,275.99 Mil) to Mar. 2024 (₩33,229.75 Mil).

HLB Therapeutics Co's annual Total Liabilities declined from Dec. 2021 (₩59,671.89 Mil) to Dec. 2022 (₩59,527.71 Mil) and declined from Dec. 2022 (₩59,527.71 Mil) to Dec. 2023 (₩29,275.99 Mil).

HLB Therapeutics Co Total Liabilities Historical Data

The historical data trend for HLB Therapeutics Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Total Liabilities Chart

HLB Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

63,422.71

21,632.28

59,671.89

59,527.71

29,275.99

HLB Therapeutics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															44,828.41	35,492.35	34,539.25	29,275.99	33,229.75

HLB Therapeutics Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

HLB Therapeutics Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	26790.664	+	(1962.389	+	194.805
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	328.133)
	=	29,276

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	200794.853	-	171518.862
	=	29,276

HLB Therapeutics Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	30557.399	+	(0	+	2672.355
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	33,230

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	211953.051	-	178723.297
	=	33,230

HLB Therapeutics Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Therapeutics Co (XKRX:115450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines